APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cytomegalovirus(CMV) Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cytomegalovirus(CMV) Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173982160326 December 2025192 pages

Choose your research edition.

Industry ResearchCytomegalovirus(CMV) Treatment Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cytomegalovirus(CMV) Treatment Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cytomegalovirus(CMV) Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cytomegalovirus(CMV) Treatment Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cytomegalovirus(CMV) Treatment Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cytomegalovirus(CMV) Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cytomegalovirus(CMV) Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cytomegalovirus(CMV) Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cytomegalovirus(CMV) Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cytomegalovirus(CMV) Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cytomegalovirus(CMV) Treatment Drugs include Takeda, Novartis, Merck, Roche, Viatris, Moderna, Gilead, Fresenius Kabi and Bausch & Lomb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cytomegalovirus(CMV) Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cytomegalovirus(CMV) Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cytomegalovirus(CMV) Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cytomegalovirus(CMV) Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Cytomegalovirus(CMV) Treatment Drugs Segment by Company

Takeda

Novartis

Merck

Roche

Viatris

Moderna

Gilead

Fresenius Kabi

Bausch & Lomb

AlphaVax

Cytomegalovirus(CMV) Treatment Drugs Segment by Type

IV Administration

Oral Administration

Cytomegalovirus(CMV) Treatment Drugs Segment by Application

Hospital

Clinic

Other

Cytomegalovirus(CMV) Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytomegalovirus(CMV) Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cytomegalovirus(CMV) Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytomegalovirus(CMV) Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cytomegalovirus(CMV) Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cytomegalovirus(CMV) Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cytomegalovirus(CMV) Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cytomegalovirus(CMV) Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cytomegalovirus(CMV) Treatment Drugs Industry Trends Table 2. Cytomegalovirus(CMV) Treatment Drugs Industry Drivers Table 3. Cytomegalovirus(CMV) Treatment Drugs Industry Opportunities and Challenges Table 4. Cytomegalovirus(CMV) Treatment Drugs Industry Restraints Table 5. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Cytomegalovirus(CMV) Treatment Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cytomegalovirus(CMV) Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cytomegalovirus(CMV) Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cytomegalovirus(CMV) Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Cytomegalovirus(CMV) Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cytomegalovirus(CMV) Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IV Administration Table 17. Major Manufacturers of Oral Administration Table 18. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Type (2021-2026) Table 22. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Type (2027-2032) Table 23. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application (2021-2026) & (K Units) Table 33. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application (2027-2032) & (K Units) Table 34. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Application (2021-2026) Table 35. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Application (2027-2032) Table 36. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application (2021-2026) & (K Units) Table 38. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application (2027-2032) & (K Units) Table 39. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Region (2021-2026) Table 44. Global Cytomegalovirus(CMV) Treatment Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cytomegalovirus(CMV) Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 48. North America Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 49. Europe Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 51. Europe Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Region (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 67. Takeda Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 77. Merck Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Roche Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 82. Roche Recent Development Table 83. Viatris Company Information Table 84. Viatris Business Overview Table 85. Viatris Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Viatris Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 87. Viatris Recent Development Table 88. Moderna Company Information Table 89. Moderna Business Overview Table 90. Moderna Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Moderna Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 92. Moderna Recent Development Table 93. Gilead Company Information Table 94. Gilead Business Overview Table 95. Gilead Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Gilead Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 97. Gilead Recent Development Table 98. Fresenius Kabi Company Information Table 99. Fresenius Kabi Business Overview Table 100. Fresenius Kabi Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Fresenius Kabi Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 102. Fresenius Kabi Recent Development Table 103. Bausch & Lomb Company Information Table 104. Bausch & Lomb Business Overview Table 105. Bausch & Lomb Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bausch & Lomb Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 107. Bausch & Lomb Recent Development Table 108. AlphaVax Company Information Table 109. AlphaVax Business Overview Table 110. AlphaVax Cytomegalovirus(CMV) Treatment Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. AlphaVax Cytomegalovirus(CMV) Treatment Drugs Product Portfolio Table 112. AlphaVax Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Cytomegalovirus(CMV) Treatment Drugs Distributors List Table 116. Cytomegalovirus(CMV) Treatment Drugs Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Cytomegalovirus(CMV) Treatment Drugs Product Image Figure 2. Global Cytomegalovirus(CMV) Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cytomegalovirus(CMV) Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Cytomegalovirus(CMV) Treatment Drugs Sales (2021-2032) & (K Units) Figure 5. Global Cytomegalovirus(CMV) Treatment Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cytomegalovirus(CMV) Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IV Administration Image Figure 9. Oral Administration Image Figure 10. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Country (2021-2032) Figure 39. China Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cytomegalovirus(CMV) Treatment Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cytomegalovirus(CMV) Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cytomegalovirus(CMV) Treatment Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cytomegalovirus(CMV) Treatment Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • IV Administration
  • Oral Administration
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Takeda
  • Novartis
  • Merck
  • Roche
  • Viatris
  • Moderna
  • Gilead
  • Fresenius Kabi
  • Bausch & Lomb
  • AlphaVax

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cytomegalovirus(CMV) Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cytomegalovirus(CMV) Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cytomegalovirus(CMV) Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cytomegalovirus(CMV) Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cytomegalovirus(CMV) Treatment Drugs Market Dynamics
  1. 2.1 Cytomegalovirus(CMV) Treatment Drugs Industry Trends
  2. 2.2 Cytomegalovirus(CMV) Treatment Drugs Industry Drivers
  3. 2.3 Cytomegalovirus(CMV) Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Cytomegalovirus(CMV) Treatment Drugs Industry Restraints
3 Cytomegalovirus(CMV) Treatment Drugs Market by Manufacturers
  1. 3.1 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cytomegalovirus(CMV) Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cytomegalovirus(CMV) Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cytomegalovirus(CMV) Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cytomegalovirus(CMV) Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Cytomegalovirus(CMV) Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cytomegalovirus(CMV) Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cytomegalovirus(CMV) Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cytomegalovirus(CMV) Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Cytomegalovirus(CMV) Treatment Drugs Market by Type
  1. 4.1 Cytomegalovirus(CMV) Treatment Drugs Type Introduction
  2. 4.1.1 IV Administration
  3. 4.1.2 Oral Administration
  4. 4.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type
  5. 4.2.1 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type
  9. 4.3.1 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Cytomegalovirus(CMV) Treatment Drugs Market by Application
  1. 5.1 Cytomegalovirus(CMV) Treatment Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application
  6. 5.2.1 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Cytomegalovirus(CMV) Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application
  10. 5.3.1 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Region
  1. 6.1 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Cytomegalovirus(CMV) Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Cytomegalovirus(CMV) Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region
  1. 7.1 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region
  2. 7.1.1 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Cytomegalovirus(CMV) Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Cytomegalovirus(CMV) Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cytomegalovirus(CMV) Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Viatris
  26. 8.5.1 Viatris Company Information
  27. 8.5.2 Viatris Business Overview
  28. 8.5.3 Viatris Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Viatris Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  30. 8.5.5 Viatris Recent Developments
  31. 8.6 Moderna
  32. 8.6.1 Moderna Company Information
  33. 8.6.2 Moderna Business Overview
  34. 8.6.3 Moderna Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Moderna Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  36. 8.6.5 Moderna Recent Developments
  37. 8.7 Gilead
  38. 8.7.1 Gilead Company Information
  39. 8.7.2 Gilead Business Overview
  40. 8.7.3 Gilead Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gilead Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  42. 8.7.5 Gilead Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Bausch & Lomb
  50. 8.9.1 Bausch & Lomb Company Information
  51. 8.9.2 Bausch & Lomb Business Overview
  52. 8.9.3 Bausch & Lomb Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bausch & Lomb Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  54. 8.9.5 Bausch & Lomb Recent Developments
  55. 8.10 AlphaVax
  56. 8.10.1 AlphaVax Company Information
  57. 8.10.2 AlphaVax Business Overview
  58. 8.10.3 AlphaVax Cytomegalovirus(CMV) Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AlphaVax Cytomegalovirus(CMV) Treatment Drugs Product Portfolio
  60. 8.10.5 AlphaVax Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cytomegalovirus(CMV) Treatment Drugs Value Chain Analysis
  2. 9.1.1 Cytomegalovirus(CMV) Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cytomegalovirus(CMV) Treatment Drugs Production Mode & Process
  6. 9.2 Cytomegalovirus(CMV) Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cytomegalovirus(CMV) Treatment Drugs Distributors
  9. 9.2.3 Cytomegalovirus(CMV) Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst